A molecular epidemiology case control study on pleural malignant mesothelioma

Area of Science:

• Oncology
• Genetics
• Environmental Health

Background:

• Pleural malignant mesothelioma is rare, typically linked to asbestos, but increasing cases with low exposure suggest cofactors are involved.
• Genetic complexity and accumulated genomic damage are characteristic of mesothelioma.
• The cytokinesis-blocked micronucleus test in peripheral blood lymphocytes (PBL) is a key method for assessing genomic damage and chromosomal instability.

Purpose of the Study:

• To evaluate micronuclei frequency in PBLs of malignant mesothelioma patients compared to lung cancer, healthy, and risk controls.
• To assess micronuclei frequency as a marker of cancer susceptibility.
• To investigate the correlation with Simian Virus 40 (SV40) presence.

Main Methods:

• Biomonitoring study using the cytokinesis-blocked micronucleus test on peripheral blood lymphocytes (PBL).
• Comparison of micronuclei frequency in patients with pleural malignant mesothelioma, lung cancer, healthy controls, and risk controls.
• Analysis for the presence of SV40 DNA sequences in T lymphocytes.

Main Results:

• Malignant mesothelioma patients exhibited significantly increased micronuclei frequency compared to all other groups.
• The mean micronuclei frequency was approximately double in mesothelioma patients versus healthy, risk, and lung adenocarcinoma controls.
• SV40 large T antigen DNA sequences were found at low prevalence in both cancer patients and controls.

Conclusions:

• Elevated micronuclei frequency in mesothelioma patients suggests significant cytogenetic damage.
• This damage may result from exogenous and endogenous cofactors in addition to asbestos exposure.
• Micronuclei frequency in PBLs could serve as a biomarker for cancer susceptibility in mesothelioma.